Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NovaQuest

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$49M
Portfolio companies 7
Rounds per year 0.24
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 4
Key employees 11
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Pharmaceutical
  • Biopharma
Summary

NovaQuest appeared to be the VC, which was created in 1982. The main department of described VC is located in the Durham. The fund was located in North America if to be more exact in United States.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the NovaQuest, startups are often financed by Vivo Capital, Technology Partners, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Roche Venture Fund, Radius Ventures, OrbiMed. In the next rounds fund is usually obtained by Aisling Capital, Roche Venture Fund, Radius Ventures.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Arvelle Therapeutics, Artisan Pharma, Sirion Therapeutics. The fund has no exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biopharma, Therapeutics.

Besides them, we counted 11 critical employees of this fund in our database.

The increased amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The top activity for fund was in 2006. Despite it in 2019 the fund had an activity. Comparing to the other companies, this NovaQuest performs on 7 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of NovaQuest:
Typical Co-investors
NovaQuest is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after NovaQuest:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerating Commercialisation - AusIndustry Australia, Australian Capital Territory, Canberra
Eneva Botafogo, Brazil, Rio de Janeiro
Future Partners Chiyoda, Japan
Israeli Founders Israel, Tel Aviv District, Tel Aviv-Yafo
JNI California, San Diego, United States
Luma Ventures Mazowieckie, Poland, Warsaw
Tsinghua Technology Transfer Fund Beijing, Beijing, China
Yuexiu Group China, Hong Kong, Hong Kong Island

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Arvelle Therapeutics

Biotechnology
$196M18 Feb 2019 Basel, Basel-City, Switzerland

Artisan Pharma

Biotechnology
Health Care
Hospital
Therapeutics
$3M20 Jul 2010 Massachusetts, United States

Protemix

Diabetes
Medical
Pharmaceutical
$14M04 Apr 2007 Auckland, New Zealand

Artisan Pharma

Biotechnology
Health Care
Hospital
Therapeutics
$39M06 Sep 2006 Massachusetts, United States

Sirion Therapeutics

Biopharma
Biotechnology
Therapeutics
19 Jun 2006 Tampa, Florida, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NovaQuest?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 49M
Rounds per year 0.24
Peak activity year 2006
Lead investments 1
Follow on index 0.20
Exits 4
Group Appearance index 0.90

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Arvelle Therapeutics

Biotechnology
$196M18 Feb 2019 Basel, Basel-City, Switzerland

Artisan Pharma

Biotechnology
Health Care
Hospital
Therapeutics
$3M20 Jul 2010 Massachusetts, United States

Protemix

Diabetes
Medical
Pharmaceutical
$14M04 Apr 2007 Auckland, New Zealand

Artisan Pharma

Biotechnology
Health Care
Hospital
Therapeutics
$39M06 Sep 2006 Massachusetts, United States

Sirion Therapeutics

Biopharma
Biotechnology
Therapeutics
19 Jun 2006 Tampa, Florida, United States
Crunchbase icon

Content report

The following text will be sent to our editors: